How do you choose labs that move fast enough in this complex environment for the lives that depend on them?
This webinar is part 3 of a multi-part series addressing key challenges facing sponsors of clinical trials and features an expert panel discussion including Ziad Peerwani, MD, Medical Director, Cleveland Clinic Laboratories; Hilmar Wisplinghoff, MD, Head of Microbiology, Labor Dr. Wisplinghoff; and Cindy Markham, Chief Commercial Officer, LabConnect. Join this webinar to gain valuable insights into how pathology & laboratory medicine can be vital in diagnosing, treating, and monitoring disease. Attendees will also learn how to accelerate their trial through advancements in molecular diagnostics, testing methodologies and automation.
Join Ziad Peerwani, MD, Medical Director, Cleveland Clinic Laboratories; Hilmar Wisplinghoff, MD, Head of Microbiology, Labor Dr. Wisplinghoff; and Cindy Markham, Chief Commercial Officer, LabConnect, for the live webinar on Monday, November 6, 2023, at 10am EST (4pm CET/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To help address these challenges, Jen Lamppa, PhD, will be hosting this webinar with guest speaker, Jacob Milliron, PharmD. Jacob is a Senior Real-World Data and Solutions Director at Inovalon and Jen serves as the Assistant Vice President of Clinical Analytics in Inovalon’s Insights.
During this webinar, the speakers will discuss integrating insights to inform clinical strategy for underrepresented patients. Attendees will have the opportunity to gain valuable insights and knowledge on how to use real-world data analytics solutions to promote DEI in clinical trials. Specifically, the webinar will cover topics such as obtaining insights into the treatment pathways for diverse populations, identifying ways to increase visibility into relevant social determinants of health (SDOH) barriers in underrepresented populations and acquiring tips on how to locate meaningful data on where and who is providing care for diverse populations.
Register for this webinar to gain valuable and actionable insights to promote DEI across the healthcare ecosystem. Join the featured speakers and be part of the impact that SDOH data has on the delivery of care, access to health services and clinical trials and patient outcomes.
Join experts from Inovalon, Jen Lamppa, PhD, AVP, Clinical Analytics; and Jacob Milliron, PharmD, MHA, Senior Real-World Data and Solutions Director, for the live webinar on Thursday, October 26, 2023, at 1pm EDT (7pm CEST/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
With over 50 years of experience, Gilson has the knowledge, expertise and equipment to support the scientific community in maintaining complete confidence in qPCR sample integrity. In this webinar, attendees will learn the fundamentals of qPCR automation and related techniques, as well as the many benefits that automation brings to the lab. Attendees will discover how labs can implement automation with practically no learning curve.
Join this webinar as the featured speaker, Jeremy Poulet Benedetti, PhD, Applications Specialist at Gilson, will explore strategies for qPCR setup and related workflows using the PIPETMAX® and the best practices for workflow optimization, liquid handling and customization. They will also cover pre-written methods, popular software choices and training opportunities.
Join the live webinar on Friday, November 03, 2023, at 10am EDT (3pm CET/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Developed in close collaboration with leading biopharma partners, Genedata Expressionist evolves with each release to meet the latest industry requirements, enabling out-of-the-box implementation of custom solutions. Genedata Expressionist 17.5 goes further by introducing an extended API that takes customization to a new level. Biopharma organizations can now seamlessly integrate bespoke software functionalities into Genedata Expressionist, enabling internal experts—or Genedata professional services—to leverage their domain knowledge and programming skills to deliver data processing, analysis, and reporting workflows that meet unique business needs.
“To maximize efficiencies in today’s data-driven drug development processes, automation must extend across entire analytical workflows, including traditional process bottlenecks such as expert review” stated Othmar Pfannes, Ph.D., CEO of Genedata. “By simplifying and accelerating data review and offering unmatched data processing flexibility, this release solidifies the position of Genedata Expressionist as the industry front-runner for streamlining and automating MS-based analytical workflows and provides biopharma organizations with faster, more accurate, and more efficient ways of working.”
About Genedata Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo. http://www.genedata.com LinkedIn https://www.linkedin.com/company/genedata/ Twitter https://twitter.com/Genedata YouTube https://www.youtube.com/GenedataSoftware
Disclaimer The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.
Join this webinar to gain insights into PK in FIH trials and how the data is essential for driving innovation and improving patient outcomes.
Join experts from Worldwide Clinical Trials, Sherilyn Adcock, RPh, PhD, Chief Scientific Officer, Early Phase Development; and Jeffrey G. Stark, PhD, Senior Director, Head of Pharmacokinetics, for the live webinar on Monday, November 06, 2023, at 11am EST (4pm GMT/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
“Deborah is worthy of this prestigious recognition for her incredible contributions to supporting the growth and advancement of women within the insurance industry,” says Jencap President Mark Maher. “Her dynamic leadership, unyielding determination, and powerful presence make her an outstanding role model.”
Through her accomplishments, Dioguardi paves the way for a more inclusive and empowering future for all women in the insurance industry.
About Jencap Group Jencap is one of the largest wholesalers in the U.S. with notable industry-leading expertise in wholesale brokerage, binding authority, and program management. Its specialized divisions and affiliate organizations provide niche underwriting prowess, broad market access, and nationwide influence. Headquartered in New York, Jencap leverages its collective power to exceed the expectations of more than 20,000 independent agency partners. For more information, visit: JencapGroup.com.
“Less than two percent of venture capital went to female-founded companies in 2022, a stat that has been stagnant for decades,” said Allyson Redpath, co-founder, Citrine. “Citrine Angels was founded with a mission to educate and encourage women to write checks to support women-owned startups. We aim to move the needle by providing an investment platform and resources for women to invest in women.”
The news is being announced during DC Startup Week, where Citrine is anchoring the Female Founders and Funders sub-track with a panel on the importance of women investing in women. Citrine is the largest angel investment group focused on women in the region. Half of Citrine’s portfolio companies are from Virginia, Maryland or Washington, D.C., as are the majority of its members.
“Making this announcement at DC Startup Week is the perfect way to celebrate such a tremendous accomplishment and drives home the message of how important it is for women to invest in women,” said Rachel Koretsky, director of DC Startup Week. “Citrine Angels deserves the most enthusiastic congratulations for their tireless support of female founders. There are so many women out there building businesses that have significant implications for the future, and organizations like Citrine are the key to bringing their ambitions and ideas to life.”
Citrine invests in early-stage venture-backable female-founded startups. While industry agnostic, 40 percent of its investments have been in consumer-related companies, 26 percent in tech and 20 percent in medical and biotech. To date, Citrine’s portfolio companies have gone on to collectively raise more than $400 million USD. Citrine accepts online applications on a year-round basis.
“From the beginning, Citrine’s approach has been to remove all barriers for investment and focus on having a continuous stream of opportunities,” said Michelle Olenoski, head of Citrine’s Deal Flow Committee. “Notably, we do not impose a minimum investment requirement on our Citrine members. This strategy has cultivated a diverse group of members, many of whom are making their inaugural venture investment. By pooling resources, our members collaborate to champion investments that range from $50,000 to $100,000 and beyond.”
Citrine’s members are accomplished female executives across a wide range of industries and backgrounds. Many members are entrepreneurs themselves or executives at well-known organizations such as Gartner, AirBnB, Amazon Web Services, Capital One and Children’s National Innovation and Research Institute. One-third of the current membership identify as Black, Indigenous, and People of Color (BIPOC) women, as do nearly half of the Board.
“I’m excited to be a part of the $1 million milestone as an investor in several portfolio companies,” said Lisa Conners, executive coach and founder of Ever Better Coaching and Consulting. “Citrine Angels provides a unique opportunity to educate myself on startup investing and to build my portfolio, all while in community with dynamic, entrepreneurial women.”
To learn more about Citrine and its portfolio companies, please visit citrineangels.com.
About Citrine Angels
Citrine Angels, a 501(c)(6) nonprofit based in the Washington, D.C. metro region, is the largest angel investing organization in the mid-Atlantic region pledged solely to the support of female-founded companies. Comprised of more than 50 women angel investors committed to empowering female entrepreneurs through investments and mentorship, Citrine aims to close the gender funding gap and increase the number of successful women-led businesses. Our focus is to provide both the financial backing and the necessary resources, networks, and expertise to help female-founded businesses grow and succeed. Visit us at citrineangels.com or follow us on LinkedIn.
“From my first contact with Support, Inc. it has been an amazing experience. The team is so friendly, easy going and open,” says Lucero. “I can’t stress enough what a gift Support Inc. has been to Tatum and our family. It has given us the ability to pay an additional caregiver of our choosing. It is such a relief to be able to provide the care that we find suitable for our daughter, while we continue to work.”
Tatum has mild intellectual disabilities. Lucero serves as Tatum’s primary family caregiver. Support, Inc. gives them access to an additional team of caregivers to provide Tatum with the help and support she needs, when she needs it – from integrated health care services and life skills development to access to community-based social activities and more.
“Support, Inc. understands the challenges and pressures that family caregivers face each day,” said Bentley Smith, CEO at Support, Inc. “We believe that caregivers should be recognized for their invaluable work and have access to the necessary support and compensation they deserve. Our Family Caregiver Program aims to alleviate the stress and burden on caregivers, ensuring they can continue to provide the highest quality care while maintaining their own well-being.”
The Family Caregiver Program offers numerous benefits to support caregivers and their loved ones, including:
Flexibility and Customized Care: Caregivers have the maximum flexibility to create their own care plans, including the option to be compensated themselves or have a family member compensated for providing care. They can also choose to hire non-family members to provide care. Support, Inc. ensures that each plan is tailored to meet the unique needs and preferences of the family.
Comprehensive Support: The program provides residential supports, respite care options, and additional resources to meet the individual needs of each family caregiver. These comprehensive supports help to alleviate the burden on caregivers and enhance the well-being of both the caregiver and their loved one.
Training and Professional Development: Support, Inc. provides caregivers with simple and clear training options at no cost in order to improve their skills. This emphasis on training contributes to the overall quality of care provided and is also a professional development opportunity for caregivers, empowering them to learn and grow.
Competitive Compensation and Benefits: Support, Inc. values the commitment and dedication of family caregivers and offers a competitive pay rate, and access to a comprehensive employment benefits plan. This ensures that caregivers receive fair compensation for their important work, providing financial stability and security.
24-Hour Support Line: The program includes a 24-hour after-hours support line, ensuring that caregivers have access to assistance and guidance whenever they need it most. This round-the-clock support gives caregivers peace of mind, knowing that help is always available.
“Here at Support, Inc., we encourage family caregivers throughout Colorado, to explore our creative Family Caregiver Program and take advantage of the comprehensive support and compensation available to them” says Smith.
With more than 33 years of experience, the Support, Inc. (https://www.supportinc.com/) team offers a wide range of residential, day and clinical services to clients across the front range of Colorado. Support, Inc. has a unique, whole-person approach that allows caregivers to develop a deep understanding of each individual’s needs. As a Program Approved Service Agency (PASA), Support, Inc. is Medicaid certified and its programs are approved by the State of Colorado. Support, Inc. is redefining the life experience for adults with intellectual and developmental disabilities.
“AdaptX is transforming the way we approach maternal health equity,” said Vicki Curtis, MSN, RN, RNC-OB, director of women’s services for USA Health Children’s and Women’s Hospital. “With self-serve data insights from AdaptX, we are able, for the first time, to rapidly identify and address disparities in care. AdaptX’s real-time perspective is helping our team generate the awareness, focus, and hope we need to deliver improvements for our patients.”
As part of this innovative maternal health initiative, USA Health Children’s & Women’s Hospital is receiving unique change management training and support from the IHI’s quality improvement experts, reflecting the IHI’s commitment to improving health equity.
“Maternal health equity reflects IHI’s core mission to improve health and healthcare worldwide. We are excited to partner with USA Health and AdaptX to tackle one of the most egregious examples of health inequity in the US,” said Pierre M. Barker, MD, MBChB, chief scientific officer of the Institute for Healthcare Improvement (IHI). “AdaptX brings powerful data capabilities that link a motivated health system to the best of improvement science. I’m hopeful that this partnership and approach will show practical solutions that will close maternal health equity gaps.”
“The AdaptX team is honored to partner with USA Health and the IHI to improve maternal health equity,” said Warren Ratliff, chief executive officer of AdaptX. “Our priority is to enable clinicians to diagnose and address disparities in care, and our team is inspired by the dedication of USA Health’s obstetrics team. We are deeply grateful for the partnership and support of the IHI and Merck for Mothers in this important work. Together, we will deepen our understanding of risks during the postpartum period and reduce inequities in morbidity and mortality.”
Healthcare leaders are using AdaptX to deliver solutions for their greatest challenges: increasing capacity and access, improving quality, enhancing equity, reducing burnout, and delivering efficiency. At a time when leaders are being asked to do more with less, AdaptX’s self-serve clinical management solution is maximizing the value of health systems’ investments in digital care.
About AdaptX
With AdaptX’s self-serve Adaptive Clinical Management™ solution, health systems transform clinical management, delivering dramatically better patient care and financial results. AdaptX’s AI-driven Mission Control Center™ empowers clinical leaders to quickly and easily leverage their real-world data to assess performance, compare approaches, and adapt – across patients, teams, protocols, workflows, and facilities.
AdaptX is headquartered in Seattle and was founded in 2016. Learn more at adaptx.com.
About USA Health
USA Health is the only academic health system along the upper Gulf Coast. With its hospitals and physician practice sites throughout the area, the health system melds clinical care, research, and healthcare education into the most advanced medical care in the region.
USA Health is nationally recognized for its Level I trauma center, comprehensive stroke center, burn center, Level III NICU, center for maternal-fetal medicine and cancer treatment. USA Health facilities include University Hospital, Children’s & Women’s Hospital, and recently acquired Providence Hospital.
About the Institute for Healthcare Improvement (IHI)
The Institute for Healthcare Improvement (IHI) is an independent not-for-profit organization based in Boston, Massachusetts, USA. For more than 30 years, IHI has used improvement science to advance and sustain better outcomes in health and health systems across the world. IHI brings awareness of safety and quality to millions, catalyzes learning and the systematic improvement of care, develops solutions to previously intractable challenges, and mobilizes health systems, communities, regions, and nations to reduce harm and deaths. IHI collaborates with a growing community to spark bold, inventive ways to improve the health of individuals and populations. IHI generates optimism, harvests fresh ideas, and supports anyone, anywhere who wants to profoundly change health and health care for the better. Learn more at ihi.org.
Xavier Duburcq, CEO of PLG, said: “This value-enhancing acquisition aligns with our disciplined M&A strategy, strengthening our position as a focused premium pharmaceutical and medical device services business, whilst further building our group’s end-to-end service offering. With this deal we are addressing the industry’s ever-growing need for best practice quality assurance due to the increasing complexity of product development, vigilance and manufacturing processes and associated regulatory requirements.”
Florent Audureau, added: “PLG is a highly regarded business that shares our commitment to delivering regulatory compliance as well as the highest quality services to the global healthcare industry. Strategiqual has been successful in building an extensive and stable client base and has inspired a high level of trust and confidence with many long-term relationships. Joining PLG provides us with an even stronger platform from which to grow our customer base, develop and scale up our offering and continue to deliver gold standard quality assurance services.”
Emmanuel Riffault, COO of PLG, commented, “Strategiqual’s unparalleled combination of business acumen, pharmaceutical and medical device expertise has formed a unique space in the Life Sciences market. We are excited to join forces with them to expand upon this platform together. This combination will significantly enhance PLG’s regulatory support services.”
About ProductLife Group:
ProductLife Group’s mission is to improve human health by delivering regulatory & compliance services for the safe and effective use of healthcare solutions. PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries. It provides consulting and outsourcing services in the areas of product development, regulatory affairs, quality management and compliance, vigilance and medical information, covering both established products and innovative therapeutics & diagnostics.
With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.
Strategiqual is a leading consultancy organization highly skilled for drugs and medical devices. Strategiqual provides companies with a full range of innovative and customized services. Strategiqual’s assets/strengths: expertise, dynamism and reactivity. This is the spirit that allows Strategiqual to offer high-quality and recognized services in the areas of regulatory affairs, market access, quality management and training.
